Skip to content

Accelerated Intermittent Theta Burst Stimulation in Unipolar Versus Bipolar Depression

Accelerated Intermittent Theta Burst Stimulation in Unipolar Versus Bipolar Depression

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06422559
Enrollment
60
Registered
2024-05-21
Start date
2024-06-01
Completion date
2025-01-01
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder

Brief summary

The goal of this interventional study is to learn if accelerated Intermittent Theta Burst Stimulation can improve symptoms of 30 participants with Unipolar depression in higher manner than symptoms of 30 participants with bipolar depression

Detailed description

We will apply stimulatory TMS protocol for participants with Unipolar depression and participants with bipolar depression using MagVenture MagPro R30 stimulator with the Cool-B65 coil

Interventions

Stimulatory TMS protocol using MagVenture MagPro R30 stimulator with the Cool-B65 coil

DEVICETMS

Stimulatory TMS protocol using MagVenture MagPro R30 stimulator with the Cool-B65 coil

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age:18\_65 years * Sex:male and female * Patients with Unipolar depression and bipolar depression diagnosis confirmed by SCID according to DSM5 * No pharmacological change in the last 4 weeks before the beginning of the stimulantion cycle * Pharmacological resistance

Exclusion criteria

* Patients complaining of psychosis.Substance Use Disorder.current suicidal ideation.major medical and neurological disorder * Patients complaining of epilepsy * pregnancy and breastfeeding * peacemaker spinal or bladder stimulator * History of skull surgery and trauma * presence of metallic foreign body

Design outcomes

Primary

MeasureTime frameDescription
Comparison of severity of manic symptoms before and after treatmentOne year for completion of the studyWe will use Young Mania Rating Scale.\_Young Mania Rating Scale:assess severity of manic symptoms, clinician rated,\<=12(remission)13\_19(minimal symptoms)20\_25(mild mania)26\_37(moderate mania)38\_60 severe mania
Comparison of the severity of the patient's illness at the time of assessment relative to the clinician's past experience with patients who have the same diagnosis.One year for completion of the studyWe will use Clinical Global Impression Severity Scale.\_Clinical Global Impression Severity Scale:rate the severity of the patient's illness at the time of assessment relative to the clinician's past experience with patients who have the same diagnosis,1 normal not at all ill,2 borderline mentally ill,3 mildly ill,4 moderately ill,5 markedly ill,6 severely ill,7 extremely ill
Comparison of severity and impact of insomnia before and after treatmentOne year for completion of the studyWe will use Insomnia Severity Index scale.\_Insomnia Severity Index:assess the nature, severity and impact of insomnia,0\_7(absence insomnia) 8\_14(subthreshold insomnia)15\_21(moderate insomnia)22\_28(severe insomnia)
Comparison of depressive symptoms before and after treatmentOne year for completion of the studyWe will use Hamilton Depression Rating Scale.\_Hamilton Depression Rating Scale:assess the severity of depressive symptoms, clinician rated,0\_7(normal range)8\_16(mild severity)17\_23(moderate severity)\>23(severe depression)

Countries

Egypt

Contacts

Primary ContactShaimaa E. Mohamed
shaimaa_eldesokey151990@yahoo.comEgypt 01014947026
Backup ContactWarda F. Aboelez
01018186408

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026